These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 8096153

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 3. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA.
    Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
    [Abstract] [Full Text] [Related]

  • 4. Membrane-associated lymphotoxin-expressing lymphokine-activated killer cells up-regulate intercellular adhesion molecule-1 expression on target tumor cells in vitro.
    Kimura K, Abe Y, Horiuchi A, Miyake M, Kimura S.
    Cell Immunol; 1995 Aug; 164(1):119-25. PubMed ID: 7634343
    [Abstract] [Full Text] [Related]

  • 5. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
    de Fries RU, Golub SH.
    J Immunol; 1988 May 15; 140(10):3686-93. PubMed ID: 3129500
    [Abstract] [Full Text] [Related]

  • 6. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.
    Rayner AA, Grimm EA, Lotze MT, Wilson DJ, Rosenberg SA.
    J Natl Cancer Inst; 1985 Jul 15; 75(1):67-75. PubMed ID: 2989604
    [Abstract] [Full Text] [Related]

  • 7. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K, Varalakshmi C, Khar A.
    Cytokines Cell Mol Ther; 1997 Mar 15; 3(1):51-8. PubMed ID: 9287244
    [Abstract] [Full Text] [Related]

  • 8. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry.
    Callewaert DM, Radcliff G, Waite R, LeFevre J, Poulik MD.
    Cytometry; 1991 Mar 15; 12(7):666-76. PubMed ID: 1782834
    [Abstract] [Full Text] [Related]

  • 9. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
    Bendall LJ, Kortlepel K, Gottlieb DJ.
    Leukemia; 1995 Apr 15; 9(4):677-84. PubMed ID: 7723403
    [Abstract] [Full Text] [Related]

  • 10. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
    Wu R, Coleman N, Stanley M.
    Chin Med J (Engl); 1996 Nov 15; 109(11):854-8. PubMed ID: 9275369
    [Abstract] [Full Text] [Related]

  • 11. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F, Kajiwara M.
    Oncol Res; 1998 Nov 15; 10(10):483-9. PubMed ID: 10338151
    [Abstract] [Full Text] [Related]

  • 12. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA, Wilson DJ, Ikejiri B, Roth JA, Grimm EA.
    J Immunol; 1986 Oct 15; 137(8):2716-20. PubMed ID: 3489774
    [Abstract] [Full Text] [Related]

  • 13. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
    Jackson AM, Alexandrov AB, Prescott S, James K, Chisholm GD.
    Immunology; 1992 Jun 15; 76(2):286-91. PubMed ID: 1353063
    [Abstract] [Full Text] [Related]

  • 14. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, Jocham D, Flad HD, Böhle A.
    Clin Cancer Res; 2000 Sep 15; 6(9):3729-38. PubMed ID: 10999767
    [Abstract] [Full Text] [Related]

  • 15. Role of LFA-3, ICAM-1, and MHC class I on the sensitivity of human tumor cells to LAK cells.
    Gwin JL, Gercel-Taylor C, Taylor DD, Eisenberg B.
    J Surg Res; 1996 Jan 15; 60(1):129-36. PubMed ID: 8592403
    [Abstract] [Full Text] [Related]

  • 16. Expression and function of LFA-1 on A-NK and T-LAK cells: role in tumor target killing and migration into tumor tissue.
    Donskov F, Basse PH, Hokland M.
    Nat Immun; 1996 Jan 15; 15(2-3):134-46. PubMed ID: 9162263
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP, Blanchard DK, Duan C, Roberts WS, Cavanagh D, DeCesare S, Djeu JY.
    J Soc Gynecol Investig; 1995 Jan 15; 2(6):762-71. PubMed ID: 9420887
    [Abstract] [Full Text] [Related]

  • 18. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J, Gulati SC.
    Stem Cells; 1993 Nov 15; 11(6):511-8. PubMed ID: 8111310
    [Abstract] [Full Text] [Related]

  • 19. ICAM-1 increases in vitro adhesion and cytotoxicity in a murine fibrosarcoma.
    Burno DK, Fabian DF, Lefor AT.
    J Surg Res; 1996 Feb 01; 60(2):398-402. PubMed ID: 8598676
    [Abstract] [Full Text] [Related]

  • 20. The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid.
    Alexander CL, Edward M, MacKie RM.
    Br J Cancer; 1999 Jul 01; 80(10):1494-500. PubMed ID: 10408388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.